European Patent Office

T 0411/02 (CTL4A receptor/BRISTOL-MYERS SQUIBB) du 07.11.2006

Identifiant européen de la jurisprudence
ECLI:EP:BA:2006:T041102.20061107
Date de la décision
7 novembre 2006
Numéro de l'affaire
T 0411/02
Requête en révision de
-
Numéro de la demande
92914009.3
Classe de la CIB
C12N 15/62
Langue de la procédure
Anglais
Distribution
Non distribuées (D)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
-
Titre de la demande
CTL4A Receptor, fusion proteins containing it and uses thereof
Nom du demandeur
Bristol-Myers Squibb Company
Nom de l'opposant
Genetics Institute
Chambre
3.3.04
Sommaire
-
Mots-clés
Admissibility of the appeals (yes)
Admission into the proceedings of documents (yes)
Admission into the proceedings of requests (yes)
Main request - added matter (yes)
Auxiliary request 1 - extention of scope of protection (yes)
Auxiliary request 2b - added matter, extention of scope of protection (no), clarity, sufficiency, novelty, inventive step (yes)
Exergue
-
Affaires citantes
T 0305/07

ORDER

For these reasons it is decided that:

1. The appeal of appellant I is admissible.

2. The decision under appeal is set aside.

3. The case is remitted to the department of first instance with the order to maintain the patent on the basis of:

- claims 1-12 of the New Auxiliary request 2b (AT, BE, ...) submitted on 6 November 2006 at the oral proceedings, for all designated states except GR and ES,

- claims 1-12 of Auxiliary Request 2b (GR), submitted on 7 November 2006 at the oral proceedings, for GR,

- claims 1-12 of Auxiliary Request 2b (ES), submitted on 7 November 2006 at the oral proceedings, for ES,

- amended pages 3, 3a, 4 and 9 of the description of EP 0 606 217 B1 dated 7 November 2006,

- pages 2, 5-8, 10-25 of the patent EP 0 606 217 B1,

- figures 1-10 of the patent EP 0 606 217 B1.